Nordea Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-388,047
| Closed | -$2.78M | – | 967 |
|
|
2022
Q2 | $2.78M | Buy |
388,047
+25,849
| +7% | +$185K | ﹤0.01% | 649 |
|
|
2022
Q1 | $4.78M | Buy |
362,198
+10,419
| +3% | +$137K | 0.01% | 596 |
|
|
2021
Q4 | $5.9M | Buy |
351,779
+1,472
| +0.4% | +$24.7K | 0.01% | 555 |
|
|
2021
Q3 | $5.75M | Sell |
350,307
-6,995
| -2% | -$115K | 0.01% | 581 |
|
|
2021
Q2 | $4.94M | Buy |
357,302
+57,385
| +19% | +$794K | 0.01% | 614 |
|
|
2021
Q1 | $4.34M | Sell |
299,917
-6,528
| -2% | -$94.5K | 0.01% | 608 |
|
|
2020
Q4 | $5.33M | Buy |
306,445
+25,098
| +9% | +$436K | 0.01% | 568 |
|
|
2020
Q3 | $5.19M | Sell |
281,347
-275,605
| -49% | -$5.08M | 0.01% | 452 |
|
|
2020
Q2 | $9.64M | Buy |
556,952
+277,514
| +99% | +$4.8M | 0.01% | 453 |
|
|
2020
Q1 | $4.68M | Buy |
279,438
+9,621
| +4% | +$161K | 0.01% | 433 |
|
|
2019
Q4 | $4.82M | Buy |
+269,817
| New | +$4.82M | 0.01% | 533 |
|